國家衛生研究院 NHRI:Item 3990099045/9365
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 858094      線上人數 : 246
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    主頁登入上傳說明關於NHRI管理 到手機版
    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/9365


    題名: Increased galectin-3 was closely associated with arterial wave reflections and provided incremental prognostic value upon natriuretic peptide in patients with acute heart failure
    作者: Cheng, HM;Sung, SH;Yu, WC;Chuang, SY;Chen, CH
    貢獻者: Division of Health Services and Preventive Medicine
    摘要: Background: Galectin-3, a marker of cardiac fibrosis, is an emergent prognostic biomarker in heart failure. However, its associations with hemodynamic parameters and whether it has an incremental prognostic value upon natriuretic peptide in acute heart failure syndrome (AHFS) remained unclear. Methods and results: Galectin-3 and N-terminal pro-brain natriuretic peptide (NT-proBNP) levels were measured in 125 participants hospitalized due to AHFS (mean age 70.4 years; 82% women). We assessed determinants of increased Galectin-3 using logistic regression model and the relation of Galectin-3 to adverse cardiovascular (CV) outcomes by proportional hazards regression. Measures of hemodynamic parameters by tonometry and thoracic fluid content (TFC) by impedance cardiography were obtained within 24 hours of admission. During a median follow-up of 601 days, 66 adverse events developed. In multivariate model, increased Galectin-3 (>25.9ng/ml) was significantly associated with estimated creatinine clearance with odd ratio (OR) 0.194 (95% confidence interval [CI] 0.101–0.373; p<0.0001) and backward arterial wave reflections (Pb; OR 2.11; 95% CI 1.20–3.71; p=0.0096). Elevated Galectin-3 was associated with risk for adverse outcomes after adjustment for clinical variables and NT-proBNP (HR: 3.49; 95% CI: 1.04 to 11.72; p=0.04). Moreover, the addition of Galectin-3 resulted in significant net incremental improvement in risk assessment (net reclassification index 0.514, 95% CI 0.078–0.949, p=0.021). Conclusion: The association of Galectin-3 with Pb linked increased Galectin-3 with small arteriolar pathology in AHFS. The independent and incremental prognostic value of Galectin-3 upon NT-proBNP lend support to the clinical application of Galectin-3 in the management of AHFS.
    日期: 2015-08
    關聯: European Heart Journal. 2015 Aug;36(Suppl.1):840.
    Link to: http://dx.doi.org/10.1093/eurheartj/ehv400
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0195-668X&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000361205105587
    顯示於類別:[莊紹源] 會議論文/會議摘要

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    ISI000361205105587.pdf107KbAdobe PDF474檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋